華映科技(000536.SZ):華映百慕大減持量過半 累計被動減持834萬股
格隆匯7月1日丨華映科技(000536.SZ)公吿稱,公司於2022年4月16日披露了《關於持股5%以上股東被動減持股份的預披露公吿》,安信證券貴陽營業部將自該預披露公吿發布之日起15個交易日後的6個月內(即2022年5月12日-11月11日),通過集中競價方式減持華映百慕大持有的公司股份,合計不超過1668萬股。
2022年7月1日公司收到安信證券貴陽營業部出具的吿知函,獲悉安信證券貴陽營業部於2022年6月24日至6月30日期間,通過集中競價交易累計減持公司股份834萬股,減持股份佔公司總股本比例為0.30%,成交金額為1,770.30萬元,減持數量已達到計劃減持數量的一半。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.